Model of SARS-CoV-2 improves drug research and development

A non-contagious model of SARSCoV2 enables more efficient research.

Researchers have developed a non-contagious model of SARS-CoV-2 that makes it easier, faster and safer to study the virus and new variants. Thanks to this model, which was developed with the support of the Swiss National Science Foundation, drugs can also be tested more effectively.